Back to search

Article

Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from <i>Mycobacterium tuberculosis</i> positive sputum

2020-09-09

Abstract excerpt

We describe the design, development, analytical performance and a limited clinical evaluation of the 10-color Xpert MTB/XDR assay (CE-IVD only, not for sale in the US). This assay is intended as a reflex test to detect resistance to Isoniazid (INH), Fluoroquinolones (FLQ), Ethionamide (ETH) and Second Line Injectable Drugs Drugs (SLID) on unprocessed sputum samples and concentrated sputum sediments which are posit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
516440de-c942-50bb-a16b-85a5b5f403a7
DOI
10.1101/2020.09.08.288787
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from <i>Mycobacterium tuberculosis</i> positive sputumDOI 10.1101/2020.09.08.288787
Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy studySemantic proximity
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection.Semantic proximity
A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum.Semantic proximity
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.Semantic proximity
Evaluation of Xpert <sup>®</sup> MTB/XDR test for susceptibility testing of <i>Mycobacterium tuberculosis</i> to first and second-line drugs in UgandaSemantic proximity
Evaluation of the Analytical Performance of the Xpert MTB/RIF AssaySemantic proximity
Access the Diagnostic Accuracy of GeneXpert to Detect <em>Mycobacterium tuberculosis</em> and Rifampicin-Resistance Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis PatientsSemantic proximity
The Pattern of rpoB gene mutation of<i>Mycobacterium tuberculosis</i>and predictors of rifampicin resistance detected by gene Xpert MTB/Rif in TanzaniaSemantic proximity
Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of<i>Mycobacterium tuberculosis</i>clinical isolates in a high-volume reference laboratorySemantic proximity
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.Semantic proximity
Xpert MTB/RIF®, a novel automated polymerase chain reaction–based tool for the diagnosis of tuberculosis [Technical note]Semantic proximity
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools.Semantic proximity
Select a neighboring publication to make it the new centre.